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Since hematopoietic stem cells (HSCs) were found to require a bone marrow (BM) habitat 
for long-term function, many studies have attempted to dissect key cellular and molecular 
interactions between HSCs and their BM microenvironments, or “HSC niches”. In this issue 
of Blood, Mende N et al. provide a computational method to infer potential ligand-receptor 
interactions between murine hematopoietic stem and progenitor cells (HSPCs) and their 
niche-forming cells1. 
Niches formed by mesenchymal stem cells (MSCs) associated with endothelial cells were 
suggested a decade ago to critically regulate HSCs2,3. In the mouse, different genetic models 
have been used to mark MSCs and essentially agreed that these cells are an important 
source of key HSC factors4,5. However, a systematic comparison among HSC-niche cells 
identified using different strategies has been lacking until recently. Moreover, single-cell 
technologies have subsequently revealed that MSCs do not escape the large heterogeneity 
observed in other stem cell populations6,7. As a consequence, some discrepancies remain 
regarding the actual source and distribution of prominent HSC factors. The variable 
specificity, expression and penetrance across genetic models is a cause of debate. For 
example, combined deletion of essential HSC factors in multiple BM cell types (or the bulk of 
non-hematopoietic BM stroma) using constitutive Cre lines reduces HSCs4,5 but cannot be 
compared with much smaller deletion in one cell population contained in the above and it 
has limited power to uncover specific HSC-niche cell interactions. The diversity of HSC 
niches is partly anatomical because different types of blood vessels and associated 
perivascular cells have been found in different BM regions, such as those in close apposition 
with the bone surface (endosteal) and those further away from bone (central). However, 
whether stromal or endothelial cells in different BM regions interact distinctly with HSCs has 
not been addressed in a systematic way. 
In this issue of Blood, Mende N et al. undertake the impressive task of cross-comparing 
mesenchymal stromal cells and endothelial cells defined immunophenotypically and using 
genetic drivers in cell populations isolated from the central and the endosteal BM of mice1. 
Through their systematic assessment they confirm the overlap of HSC niche cell populations 
identified using different strategies – which had been suggested in previous studies – and 
identify interesting differences among cell populations harvested from endosteal and 
central BM (see figure). For instance, MSCs harvested from central or endosteal BM show 
distinct transcriptional profiles. Together with the reportedly higher resistance of endosteal 
MSCs to myeloablation and the described functions of some endosteal mesenchymal cells, 
such as N-cadherin+ cells8, these results add further evidence to the possibility that different 
BM niches might regulate steady-state vs. stress hematopoiesis. 
As a major novel aspect, the authors develop a computational method to infer potential 
ligand-receptor interactions between niche cells and HSPCs based on mRNA expression 
levels. A ranking and matching algorithm assigns highly expressed ligands (either agonists or 
antagonists) in niche cells to putative receptors in HSPCs. Confirmation of key known 
interactions validates this method, which suggests potential novel interactions between 
HSPCs and their niches1. 
Previous studies have cross-compared the gene expression signatures of murine HSC-
supporting and -non supporting stromal cell lines and have identified a modular network of 
paracrine signalling including most known and potential new HSC regulators9. 
Following the identification of new candidate interactive partners between HSCs and some 
niche cells, it would be interesting to functionally test them. The Wascow lab has already 
started this task by investigating the effect of several regulators on HSPCs in vitro1. 
Since the study by Mende et al. suggests differential interactions between HSPCs and CD31hi 
CD144+ (putative arteriolar) endothelial cells or MSCs, it would be interesting to expand 
these analyses to other HSC-niche cells, such as CD31lo sinusoidal endothelial cells and 
megakaryocytes, for example. It is worth mentioning that this extensive cross-comparison of 
mouse models and prospectively identified HSC niche cells1 has been performed at the cell 
population level. Following the development of HSC niche single-cell technologies6,7, a 
natural extension of the current work would be applying these interactome algorithms to 
single cell transcriptomics and/or examining candidate interactome pathways using 
additional markers and single-cell RNAseq (or index sorting) to discriminate the specific cell 
types critically interacting with HSCs through novel pathways. 
On a practical note, it would be very useful for the research community to develop a 
publicly available online resource to facilitate the application of the elegant mathematical 
algorithm developed by Höffer and colleagues1 to the analyses of ligand-receptor 
interactions in other datasets by different laboratories. In that regard, other publicly 
available resources, such as the HSC niche database (http://stemniche.snv.jussieu.fr/), 
which allows to interrogate mRNA or miRNA expression in murine HSC-supporting stromal 
cells9, or an interactive browser to interrogate gene expression in single BM vascular, 
perivascular and osteolineage cells (http://aifantislab.com/niche/)6 have proven useful tools 
to investigate HSC niche cell transcriptomics. 
Finally, future efforts in this area will need to include proteomics analysis since mRNA 
expression does not always correlate with protein abundance. This is particularly relevant 
for cytokine or chemokine receptors, which are often regulated by post-transcriptional 
mechanisms. Therefore, an important challenge for future studies is the extrapolation of 
candidate receptor-ligand interactions inferred from mouse transcriptomics to the human 
proteome. In this regard, age-associated alterations of HSPCs and their niches described in 
the human proteome resemble those previously found through mouse genetics10, 
suggesting the potential translatability of these findings in general. 
Figure Legend: In this issue of Blood, Mende et al.1 use a variety of Cre lines targeting 
multiple non-hematopoietic cells of the BM microenvironment. They attempt to resolve 
previous discrepancies in the field whereby the overlap between niche cells targeted by 
different Cre lines was underestimated because only subsets among those Cre-targeted cells 
had been characterized. For that goal they use several reporters and perform RNAseq from 
immunophenotypically-identified HSPCs and mesenchymal stromal cells, endothelial cells 
and preosteoblasts isolated from bone-associated (endosteal) BM or located further from 
bone (central). Matching top expressed ligands in niche cells with the most highly expressed 
receptors on HSPCs provides a candidate HSPC-niche interactome containing some old and 
many new potential HSPC regulators. 
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